4.6 Article

Genome-wide association study of hippocampal atrophy rate in non-demented elders

Journal

AGING-US
Volume 11, Issue 22, Pages 10468-10484

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/aging.102470

Keywords

hippocampal atrophy rate; cognitive decline; genome-wide association study

Funding

  1. National Key R&D Program of China [2016YFC1305803]
  2. National Natural Science Foundation of China [91849126, 81571245, 81771148]
  3. Shanghai Municipal Science and Technology Major Project [2018SHZDZX01]
  4. ZHANGJIANG LAB
  5. Tianqiao and Chrissy Chen Institute
  6. State Key Laboratory of Neurobiology of Ministry of Education, Fudan University
  7. Frontiers Center for Brain Science of Ministry of Education, Fudan University
  8. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  9. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  10. National Institute on Aging
  11. National Institute of Biomedical Imaging and Bioengineering
  12. AbbVie
  13. Alzheimer's Association
  14. Alzheimer's Drug Discovery Foundation
  15. Araclon Biotech
  16. BioClinica, Inc.
  17. Biogen
  18. Bristol-Myers Squibb Company
  19. CereSpir, Inc.
  20. Cogstate
  21. Eisai Inc.
  22. Elan Pharmaceuticals, Inc.
  23. Eli Lilly and Company
  24. EuroImmun
  25. F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
  26. Fujirebio
  27. GE Healthcare
  28. IXICO Ltd.
  29. Janssen Alzheimer Immunotherapy Research and Development, LLC.
  30. Johnson and Johnson Pharmaceutical Research and Development LLC.
  31. Lumosity
  32. Lundbeck
  33. Merck and Co., Inc.
  34. Meso Scale Diagnostics, LLC.
  35. NeuroRx Research
  36. Neurotrack Technologies
  37. Novartis Pharmaceuticals Corporation
  38. Pfizer Inc.
  39. Piramal Imaging
  40. Servier
  41. Takeda Pharmaceutical Company
  42. Transition Therapeutics
  43. Canadian Institutes of Health Research

Ask authors/readers for more resources

Hippocampal atrophy rate has been correlated with cognitive decline and its genetic modifiers are still unclear. Here we firstly performed a genome-wide association study (GWAS) to identify genetic loci that regulate hippocampal atrophy rate. Six hundred and two non-Hispanic Caucasian elders without dementia were included from the Alzheimer's Disease Neuroimaging Initiative cohort. Three single nucleotide polymorphisms (SNPs) (rs4420638, rs56131196, rs157582) in the TOMM40-APOC1 region were associated with hippocampal atrophy rate at genome-wide significance and 3 additional SNPs (in TOMM40 and near MIR302F gene) reached a suggestive level of significance. Strong linkage disequilibrium between rs4420638 and rs56131196 was found. The minor allele of rs4420638 (G) and the minor allele of rs157582 (T) showed associations with lower Mini-mental State Examination score, higher Alzheimer Disease Assessment Scale-cognitive subscale 11 score and smaller entorhinal volume using both baseline and longitudinal measurements, as well as with accelerated cognitive decline. Moreover, rs56131196 (P = 1.96 x 10(-454)) and rs157582 (P = 9.70 x 10(-434)) were risk loci for Alzheimer's disease. Collectively, rs4420638, rs56131196 and rs157582 were found to be associated with hippocampal atrophy rate. Besides, they were also identified as genetic loci for cognitive decline.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available